Building A
Pain Therapeutics Powerhouse

Targeting Pain
At Its Source

We are passionate about our commitment to developing safe and innovative pain treatments that address the limitations of currently available therapies, such as opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), hyaluronic acid (HA) injections and surgery.

Learn More

Leadership Team

Our company is led by a seasoned team of biotech and pharmaceutical executives with vast expertise in clinical development, commercial operations and business development, and an impressive and proven track record of bringing new safe and effective therapeutics to people who suffer from chronic pain.

Meet Us

Our Approach

Our approach to drug discovery and development is fueled by our in-depth understanding of the biology of pain, combined with proprietary insights mined from big data and translational science.

Learn More

Our Pipeline

We are advancing a valuable, unique and diversified pipeline of non-opioid treatments for chronic pain through internal development and strategic in-licensing.

Learn More

Clinical Trials

We are currently advancing several promising pipeline candidates through various stages of the clinical development pathway.

Learn More

Why Pain?

Despite a broad range of therapeutics and interventions, pain continues to pose a significant burden on a global scale, with an estimated 100 million people living with chronic pain in the U.S. alone. We believe that our pipeline is uniquely positioned to address the limitations of currently available therapies by providing safe, effective and long-term pain treatment solutions.

Learn More